Marpai Q2 Loss Widens, Cash Drops to $138K; Going Concern Warning Reiterated
MRAI has more than doubled off its 52-week low of $0.215 on light trading volume (0.2× avg).
Summary
Marpai reported a wider Q2 loss and critically low cash reserves, reiterating its going concern warning. The filing details recent financing and debt restructuring that buy time but add dilution and future liabilities.
Key Events · Earnings and Guidance · MRAI
-
Q2 Revenue Falls 10.5%
Revenue declined to $4.17 million from $4.66 million a year ago, driven by customer turnover. Six-month revenue fell 14.5% to $8.61 million.
-
Net Loss Widens
Q2 net loss was $4.58 million, up from $4.37 million last year. Six-month net loss reached $7.77 million.
-
Cash Position Critical
Unrestricted cash was only $138,000 as of June 30, 2026, with negative working capital of $14.5 million. Management reiterates substantial doubt about going concern.
-
$12.1M Preferred Offering Details
The company sold 12,100 shares of Series A Preferred Stock at $1,000 per share for gross proceeds of $12.1 million. $2.45 million of net proceeds is payable to AXA.
Analysis · MRAI · Industrial Applications And Services
Marpai's Q2 2026 results show revenue declining 10.5% year-over-year to $4.17 million while the net loss widened to $4.58 million. The company's unrestricted cash has dwindled to just $138,000, and management reiterates substantial doubt about its ability to continue as a going concern. The filing also details the $12.1 million preferred stock offering and the AXA debt restructuring, which provide temporary relief but come with significant dilution and future payment obligations.
At the time of this filing, MRAI was trading at $2.19 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $58.8M. The 52-week trading range was $0.22 to $2.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.